Pharmaceutical Traceability Code Scanning All-in-One Machine Research:CAGR of 7.3% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Pharmaceutical Traceability Code Scanning All-in-One Machine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Pharmaceutical Traceability Code Scanning All-in-One Machine market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Pharmaceutical Traceability Code Scanning All-in-One Machine was estimated to be worth US$ 284 million in 2025 and is projected to reach US$ 467 million, growing at a CAGR of 7.3% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5554167/pharmaceutical-traceability-code-scanning-all-in-one-machine

Pharmaceutical Traceability Code Scanning All-in-One Machine Product Introduction

The Pharmaceutical Traceability Code Scanning All-in-One Machine is an integrated smart terminal specifically designed for pharmaceutical lifecycle traceability management. It combines a high-precision barcode/QR code scanning module, embedded data processing unit, human-machine interface display, and wireless/wired communication modules. It is primarily deployed in pharmacies, hospital pharmacies, pharmaceutical warehousing and logistics nodes, and retail outlets. This device rapidly and accurately reads the unique traceability identifier (traceability code) on the smallest unit of sale packaging. by connecting in real-time to the National Drug Traceability Collaborative Service Platform or internal enterprise traceability management systems. It enables instant drug information queries, distribution flow tracking, authenticity verification, inventory ledger synchronization, and traceability data uploads. Its integrated design streamlines operational workflows, enhancing the efficiency and accuracy of drug traceability. This intelligent tool is crucial for implementing drug traceability management systems, ensuring drug quality and safety, and standardizing pharmaceutical distribution practices.

According to the new market research report "Global Pharmaceutical Traceability Code Scanning All-in-One Machine Market Report 2026-2032", published by QYResearch, the global Pharmaceutical Traceability Code Scanning All-in-One Machine market size is projected to reach USD 0.47 billion by 2032, at a CAGR of 7.3% during the forecast period.

Figure00001. Global Pharmaceutical Traceability Code Scanning All-in-One Machine Market Size (US$ Million), 2026 VS 2032

Pharmaceutical Traceability Code Scanning All-in-One Machine

Above data is based on report from QYResearch: Global Pharmaceutical Traceability Code Scanning All-in-One Machine Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

Figure00002. Global Pharmaceutical Traceability Code Scanning All-in-One Machine Top 12 Players Ranking and Market Share (Ranking is based on the revenue of 2025, continually updated)

Pharmaceutical Traceability Code Scanning All-in-One Machine

Above data is based on report from QYResearch: Global Pharmaceutical Traceability Code Scanning All-in-One Machine Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Pharmaceutical Traceability Code Scanning All-in-One Machine include Soman Technology, SUPOIN, iData, Urovo, ivysun, Rakinda, Seuic, Dingyu Iot, DONSEE, Xindeli Tech, etc. Manufacturers of pharmaceutical traceability code scanning all-in-one machines are mainly concentrated in East Asia (especially China), Western/Central Europe, and North America, because these regions pair highly developed automation and machine-vision manufacturing bases with dense electronics/component supply chains, strong pharmaceutical packaging and logistics ecosystems, and strict serialization/track-and-trace compliance requirements that drive rapid product iteration, certification readiness, and scalable global deployment.

Table 1. Pharmaceutical Traceability Code Scanning All-in-One Machine Industry Chain Analysis

Item

Description

Upstream

Core Hardware Component Suppliers

Manufacturers of scanning modules, display screens, circuit boards, and processors (key parts supporting code recognition and device operation)

Raw Material Suppliers

Providers of plastic casings, metal structural parts, and wiring materials (for physical machine assembly)

Software Developers

Teams developing traceability system algorithms, data encryption tools, and basic operating software (tailored to pharmaceutical data security and regulatory requirements)

Midstream

Machine Manufacturers & R&D Institutions

Machine manufacturers: Entities responsible for hardware assembly, software integration, and finished product production of the Pharmaceutical Traceability Code Scanning All-in-One Machine

R&D institutions: Organizations focused on developing pharmaceutical-specific functions (e.g., drug unique identification (UID) recognition, docking with national pharmaceutical traceability platforms)

Downstream

Pharmaceutical Manufacturers

Use the machine for drug coding, labeling, and initial traceability data entry

Pharmaceutical Distributors

Apply it to track drug flow across the supply chain

Retail Pharmacies/Hospitals

Utilize it to verify drug authenticity and query product circulation information

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2026

Table 2. Pharmaceutical Traceability Code Scanning All-in-One Machine Industry Policy Analysis

Policy

Description

1

China medical-insurance traceability-code collection acceleration (NHSA)

China's NHSA has expanded and formalized traceability-code information collection for reimbursed drugs/consumables (notably scaling pilots across provinces and issuing operational requirements and scope clarifications), which increases adoption of "scan-at-dispense/settlement" workflows and boosts demand for reliable all-in-one devices supporting compliant capture, online validation, and data upload.

2

U.S. DSCSA interoperability enforcement (post-stabilization + targeted exemptions)

FDA's DSCSA "enhanced drug distribution security" requirements shifted from the broad stabilization period ending Nov 27, 2024 into a phase where remaining exemptions/waivers (e.g., additional time for certain small dispensers and limited transitional relief) still require industry to operate interoperable electronic tracing-driving packaging-line demand for higher-speed scan/verify, exception handling, and serialized data exchange readiness.

3

EU FMD safety-features continuity (no added "whitelisting" + evolving regional application)

The EU continues to enforce FMD safety features (2D code + tamper evidence) with the European Commission stating there are no plans to exempt additional categories ("whitelisting"), while regional applicability changes (e.g., Northern Ireland disapplying EU FMD from 2025) reinforce the need for flexible, standards-compliant code verification and packaging-line validation designs.

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2026

Table 3. Pharmaceutical Traceability Code Scanning All-in-One Machine Industry Development Trends

Development Trends

Description

1

Intelligent Function Deepening

This trend centers on embedding advanced intelligent capabilities into the machines: it involves integrating AI algorithms to enable automatic error correction for blurred or damaged drug codes (boosting recognition accuracy to ≥99.8%) and intelligent scanning data analysis (such as automatically flagging abnormal drug batch circulation), while also adding IoT-based device status monitoring to support real-time alerts for malfunctions like scanning module failures and automatic reporting of operational metrics (e.g., daily scanning volume) to centralized management platforms.

2

Multi-modal Code Recognition Expansion

This trend focuses on broadening the machines' code recognition capabilities: it includes expanding compatibility to simultaneously identify diverse formats (1D codes, 2D codes, RFID tags, and high-density micro-codes, suited for small pharmaceutical packages) and enhancing anti-interference performance, allowing accurate scanning of codes with stains, wrinkles, or partial coverage-addressing the common issue of code damage in logistics links.

3

Scene-customized & Lightweight Design

This trend revolves around adapting machines to specific pharmaceutical scenarios and optimizing their usability: it entails launching tailored models like portable handheld machines (for space-constrained retail pharmacies/hospitals), batch high-speed scanning machines (for high-volume manufacturers/distributors), and wall-mounted integrated machines (for fixed-point monitoring), while also reducing machine weight by 20-30% and enhancing casing wear resistance to suit high-frequency daily use in these settings.

4

Full-chain Digital System Integration

This trend emphasizes connecting the machines to broader digital ecosystems: it involves achieving seamless docking with upstream and downstream systems (including pharmaceutical enterprises' ERP/WMS systems, national drug traceability platforms, and retail terminal management systems, enabling one-click cross-system synchronization of scanning data) and supporting cloud-based centralized management, which allows remote monitoring, parameter adjustment, and data analytics for multiple machines to help enterprises refine supply chain efficiency using scanning data insights.

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2026

Table 4. Pharmaceutical Traceability Code Scanning All-in-One Machine Industry Development Opportunities

Development Opportunities

Description

1

Policy-driven Full Coverage Demand

Supported by recent regulatory policies (e.g., the 2023 Revised Implementation Rules for the Drug Traceability System and the 2024-2026 Smart Pharmaceutical Supply Chain Equipment Promotion Plan), this opportunity stems from the mandatory requirement for all pharmaceutical circulation entities (manufacturers, distributors, retail pharmacies, hospitals) to equip compliant traceability code scanning all-in-one machines. In particular, sinking markets (third- and fourth-tier cities, county-level medical institutions) currently have low equipment penetration rates, creating a large-scale demand gap for standardized machines to meet regulatory compliance.

2

Intelligent Upgrade Replacement Demand

As the industry shifts toward intelligent functions (e.g., AI code error correction, IoT monitoring), this opportunity arises from the replacement cycle of basic, non-intelligent machines currently in use. Existing users (such as large pharmaceutical manufacturers and chain pharmacies) are actively upgrading to intelligent all-in-one machines to improve scanning efficiency and data value, while new users prefer intelligent models directly, driving growth in high-value, feature-rich machine sales.

3

Adjacent Scenario Application Expansion

This opportunity lies in extending the machines' application beyond traditional pharmaceutical product traceability to adjacent regulated sectors: many regions are expanding traceability requirements to medical devices, veterinary drugs, and health food products, and the core code-scanning and data-docking functions of these machines can be adapted to these scenarios with minor parameter adjustments, opening up new market segments beyond the pharmaceutical industry.

4

Data Value Mining & Collaborative Service Opportunities

Since traceability code scanning machines collect large volumes of drug circulation data (e.g., batch flow, scanning frequency), this opportunity involves collaborating with pharmaceutical enterprises, supply chain tech platforms, and regulatory bodies to provide value-added data services (e.g., supply chain optimization analysis, inventory turnover forecasting) alongside hardware sales. This transforms one-time equipment transactions into recurring revenue streams via data-driven service models.

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2026

Table 5. Pharmaceutical Traceability Code Scanning All-in-One Machine Obstacles/Challenges to Industry Development

Obstacles/Challenges

Description

1

High Compliance & Technical Thresholds

The industry faces strict multi-dimensional compliance requirements (e.g., GMP pharmaceutical standards, national data security norms, traceability platform docking specifications), which requires manufacturers to invest heavily in R&D, testing, and certification to meet dynamic regulatory updates. Additionally, the need to adapt to evolving technical standards (e.g., new drug code formats, intelligent function upgrades) raises the entry barrier, especially for small and medium-sized equipment manufacturers with limited R&D capabilities.

2

Cost Pressure for Small & Medium-sized End-users

Small-scale pharmaceutical entities (e.g., county-level pharmacies, small distributors) face significant cost burdens: mandatory purchase of compliant all-in-one machines, plus follow-up expenses for maintenance, software upgrades, and data docking. While policy subsidies cover part of the cost, the residual financial pressure slows down equipment penetration in sinking markets, hindering full-industry traceability coverage.

3

Data Interoperability & Standardization Gaps

Disparate data formats and interface standards exist across different systems (e.g., enterprise ERP/WMS, regional traceability platforms, national drug supervision systems), leading to poor synchronization of scanning data between systems and reducing the efficiency of full-chain traceability. Additionally, inconsistent drug code printing standards (e.g., varying code sizes, quality) across some pharmaceutical manufacturers cause recognition failures, affecting the machines' practical application effects.

4

After-sales Service & Maintenance Bottlenecks

The uneven distribution of after-sales service networks (especially in remote areas) leads to delayed maintenance for faulty machines, which risks disrupting pharmaceutical circulation traceability and regulatory compliance. Meanwhile, insufficient technical training for end-users (e.g., pharmacy staff) results in underutilization of the machines' intelligent functions (e.g., data analysis, IoT monitoring), limiting the value these devices can deliver.

Source: Secondary Sources, Press Releases, Expert Interviews and QYResearch, 2026

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Pharmaceutical Traceability Code Scanning All-in-One Machine market is segmented as below:
By Company
Soman Technology
SUPOIN
iData
Urovo
ivysun
Seuic
DONSEE
Xindeli Tech
snbc
Joyusing tch
Rakinda
Dingyu Iot

Segment by Type
Imaging Code Scanning All-in-One Machine
Laser Code Scanning All-in-One Machine
Others

Segment by Application
Pharmaceutical Companies
Hospital Pharmacies
Community Pharmacies
Other

Each chapter of the report provides detailed information for readers to further understand the Pharmaceutical Traceability Code Scanning All-in-One Machine market:

Chapter 1: Introduces the report scope of the Pharmaceutical Traceability Code Scanning All-in-One Machine report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Pharmaceutical Traceability Code Scanning All-in-One Machine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Pharmaceutical Traceability Code Scanning All-in-One Machine market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Pharmaceutical Traceability Code Scanning All-in-One Machine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Pharmaceutical Traceability Code Scanning All-in-One Machine in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Pharmaceutical Traceability Code Scanning All-in-One Machine competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Pharmaceutical Traceability Code Scanning All-in-One Machine comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Pharmaceutical Traceability Code Scanning All-in-One Machine market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Pharmaceutical Traceability Code Scanning All-in-One Machine Market Research Report 2026
Global Pharmaceutical Traceability Code Scanning All-in-One Machine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com

This release was published on openPR.